Steven Paul has been elected to Sigma-Aldrich’s board of directors, the company said this week.
Paul is the executive vice president for science and technology and president of the Lilly Research Laboratories of Eli Lilly. Prior to this, Paul was scientific director of the National Institute of Mental Health.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
